Trial Profile

Phase 3 clinical study of Vezocolmitide

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 30 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vezocolmitide (Primary)
Indications Dry eyes
Focus Registrational; Therapeutic Use
Sponsors Stuart Therapeutics

Most Recent Events

30 Jun 2025 New trial record
24 Jun 2025 According to Stuart Therapeutics media release, company is finalizing a plan for an additional clinical trial using the results from the present Phase III trial to help guide the trial design. The Company also intends to engage with the U.S. Food and Drug Administration (FDA) to confirm the design of this additional trial, and the regulatory path to approval of ST-100.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com